Interleukin-17 antagonism inhibits acute but not chronic vascular rejection

Transplantation

Volumn 72, Issue 2, 2001, Pages 348-350

  Tang, Jian Lin ^a   Subbotin, Vladimir M ^a   Antonysamy, Mary A ^a   Troutt, Anthony B ^b   Rao, Abdul S ^a   Thomson, Angus W ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; HYBRID PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; INTERLEUKIN 17;

ABDOMINAL AORTA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; COLLAGEN METABOLISM; CONTROLLED STUDY; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; VASCULAR DISEASE;

EID: 0034898588     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200107270-00035     Document Type: Article

References (10)

1. IL-17: A novel cytokine derived from T cells
2. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines
3. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-β and TNF-α by human macrophages
4. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways
5. Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors
6. An improved surgical technique for the establishment of a murine model of aortic transplantation
7. Flt-3 ligand increases microchimerism but can prevent the therapeutic effect of donor bone marrow in transiently immunosuppressed cardiac allograft recipients
8. Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients
9. gld (CD95L) mutant recipients: The role of alloantibodies in the development of chronic rejection
10. Early risk factors contributing to the evolution of long-term allograft dysfunction